CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 49  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1028
LYS 10.0138
GLU 20.0100
LEU 30.0111
ARG 40.0086
CYS 50.0093
GLN 60.0073
CYS 70.0189
ILE 80.0350
LYS 90.0226
THR 100.0141
TYR 110.0281
SER 120.0508
LYS 130.0428
PRO 140.0372
PHE 150.0188
HIS 160.0302
PRO 170.0206
LYS 180.0284
PHE 190.0100
ILE 200.0084
LYS 210.0269
GLU 220.0253
LEU 230.0141
ARG 240.0146
VAL 250.0112
ILE 260.0133
GLU 270.0169
SER 280.0109
GLY 290.0080
PRO 300.0025
HIS 310.0079
CYS 320.0029
ALA 330.0228
ASN 340.0172
THR 350.0167
GLU 360.0041
ILE 370.0048
ILE 380.0113
VAL 390.0121
LYS 400.0134
LEU 410.0129
SER 420.0312
ASP 430.1028
GLY 440.0421
ARG 450.0552
GLU 460.0105
LEU 470.0119
CYS 480.0131
LEU 490.0063
ASP 500.0013
PRO 510.0061
LYS 520.0260
GLU 530.0069
ASN 540.0211
TRP 550.0172
VAL 560.0055
GLN 570.0072
ARG 580.0094
VAL 590.0113
VAL 600.0194
GLU 610.0295
LYS 620.0283
PHE 630.0266
LEU 640.0303
LYS 650.0393
ARG 660.0209
ALA 670.0149
GLU 680.0539
ASN 690.0652

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.